Josefina Ricardo-Garcell

Josefina Ricardo-Garcell

Auto-generated profile, based on publicly available information

Josefina Ricardo-Garcell

Instituto de Neurobiología, Universidad Nacional Autónoma de México

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in International Journal of Psychophysiology
Verified
Journal Article
Closed access
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
JGJorge J. González-Olvera
Jorge J. González-Olvera
EMEdgar Miranda
Edgar Miranda
THThalía Harmony
Thalía Harmony
ERErnesto Reyes
Ernesto Reyes
EAEduardo Aubert
Eduardo Aubert

12 June 2017 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JRJulian Reyes-López
Julian Reyes-López
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
GAGabriela Armas-Castañeda
Gabriela Armas-Castañeda
María L García AnayaMaría L García Anaya
María L García Anaya
IMIván Arango-De Montis
Iván Arango-De Montis
FPFrancisco Pellicer
Francisco Pellicer
Key words: Borderline personality disorder; neurophysiology; neurosciences; psychosocial factors

1 February 2021 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
ACAngel R. Calderón-Moctezuma
Angel R. Calderón-Moctezuma
JRJulián Reyes-López
Julián Reyes-López
RRRené Rodríguez-Valdés
René Rodríguez-Valdés
MBMario Barbosa-Luna
Mario Barbosa-Luna
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
HHHebert Hernández-Montiel
Hebert Hernández-Montiel
Objective: Current treatment for borderline personality disorder (BPD) involves psychological and pharmacological interventions. However, neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) may positively affect BPD symptomatology. The objective of this study was to evaluate the clinical and neuropsychological effects of rTMS on the dorsomedial prefrontal cortex (DMPFC) in BPD patients. Methods: Fourteen patients with BPD were randomized into two groups (active vs. sham) for 15 sessions of rTMS on the DMPFC. Clinical effects were measured using the Borderline Symptoms List (BSL), Clinical Global Impression Scale for BPD (CGI-BPD), Borderline Evaluation of Severity over Time (BEST), Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), and Barratt’s Impulsiveness Scale (BIS). Neuropsychological effects were determined by a Stop-Signal Task (SST), the Wisconsin Card-Sorting Test (WCST), and the Iowa Gambling Test (IGT). Results: Within-group comparison showed significant differences (p < 0.05) in CGI-BPD (total score and six of nine psychopathologic domains), BEST, HDRS, HARS, and IGT scores for active modality. Conclusion: The 5 Hz-DMPFC rTMS technique was well tolerated and lessened the severity of BPD symptomatology, especially abandonment, affective issues, interpersonal relationships, suicidal behavior, anger, and paranoid ideation. Cognitive improvement was seen in decision-making. Additional studies are needed to fully evaluate the effects of rTMS on BPD symptomatology. Clinical Trial Registration: NCT03832777.

28 October 2021 in NeuroReport
Verified
Journal Article
Closed access
GAGabriela Armas-Castañeda
Gabriela Armas-Castañeda
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
JRJulian V. Reyes
Julian V. Reyes
GHGerhard Heinze
Gerhard Heinze
RSRafael J Salín
Rafael J Salín
JGJorge J. González
Jorge J. González
Introduction: Depression is one of the leading causes of disability in the world, and a disease that contributes greatly to the global burden of disease. Repetitive transcranial magnetic stimulation (rTMS) has proven to be a well-tolerated, effective treatment for depression. The present study was designed to evaluate the efficacy of an rTMS treatment scheme with a fewer number of sessions per week. Methods: In total 91 adult university students with major depressive disorder (MDD). This was a double-blind, randomized clinical trial in which 15 sessions of rTMS were given to each one of two treatment groups made up of adults with active MDD. One treatment group received two sessions per week, the other received five. The study protocol included their respective sham rTMS groups. The patients who received active rTMS also participated in a follow-up procedure that consisted of two sessions of active rTMS per month for three more months. Results: Measurements by the Hamilton Rating Scale for Depression (HAMD) showed that the groups which received active rTMS had higher percentages of antidepressant response at 96 and 95.5% for five and two sessions/week, respectively, compared to the sham rTMS groups: 27.3 and 4.5% for five and two sessions/week, respectively. Observations at the end of the 3-month follow-up phase showed that the improvements in HAMD scores were maintained in both groups. Conclusion: This study contributes to demonstrating that rTMS with a more practical schedule of two sessions/week is an effective antidepressant treatment that could be considered the first choice for managing symptoms of depression.

23 April 2018 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
LCLourdes Cubero-Rego
Lourdes Cubero-Rego
MCMaría Corsi‐Cabrera
María Corsi‐Cabrera
JRJosefina Ricardo‐Garcell
Josefina Ricardo‐Garcell
RCRogelio Cruz‐Martínez
Rogelio Cruz‐Martínez
THThalia Harmony
Thalia Harmony

1 January 2013 in Salud mental
Verified
Journal Article
Open access
PDF file
JGJorge J. González-Olvera
Jorge J. González-Olvera
JRJosefina Ricardo-Garcell
Josefina Ricardo-Garcell
MGMaría del Lourdes García-Anaya
María del Lourdes García-Anaya
EMEdgar Miranda-Terrés
Edgar Miranda-Terrés
ERErnesto Reyes-Zamorano
Ernesto Reyes-Zamorano
GAGabriela Armas-Castañeda
Gabriela Armas-Castañeda
La estimulación magnética transcraneal repetitiva (EMTr) es una técnica que permite estimular eléctricamente la corteza cerebral de manera no invasiva y con pocos efectos secundarios. Se ha propuesto que la EMTr aplicada sobre la corteza prefrontal dorsolateral (CPFDL) izquierda con frecuencias =5Hz tiene efectos antidepresivos. Se ha encontrado que en el electroencefalograma cuantitativo (QEEG por sus siglas en ingles) la mayoría de pacientes deprimidos presentan incrementos en las bandas theta y alfa, así como asimetrías interhemisféricas en la actividad alfa en regiones anteriores. La EMTr sobre la CPFDL izquierda a 5Hz ofrece ventajas considerables en seguridad y tolerabilidad; sin embargo, sus correlatos neurofisiológicos no han sido explorados por el análisis de fuentes del EEG. Objetivo. Estudiar los cambios en las fuentes del EEG según el método VARETA en un grupo de pacientes con trastorno depresivo mayor que recibieron EMTr a 5Hz sobre la corteza prefrontal dorsolateral izquierda como tratamiento único o en combinación con escitalopram. Material y métodos. Se estudiaron 18 pacientes con diagnostico de trastorno depresivo mayor de acuerdo con los criterios del DSM-IV sin tratamiento para el episodio en curso. Los sujetos habían sido aleatoriamente asignados a uno de los siguientes grupos de tratamiento: A) EMTr+escitalopram 10mg, n=9; B) EMTr+placebo, n=9. Se aplico EMTr, a 5Hz en una sesión diaria durante 15 días. Se obtuvieron dos registros electro-encefalográficos, uno basal y otro final, con el fin de comparar los cambios en las fuentes de actividad eléctrica cerebral, pre-tratamiento y post-tratamiento. Se realizaron evaluaciones clinimétricas con las escalas de Hamilton para Depresión y Ansiedad y el Inventario de Depresión de Beck. Resultados. Todos los pacientes en el grupo A y ocho pacientes en el grupo B respondieron al tratamiento, con una reducción de 50% o más en la escala HDRS. En el análisis de fuentes se encontró un efecto en el grupo B caracterizado por incremento en la PA de 9.37 a 10.17Hz, en regiones temporales y giro poscentral izquierdos, mismo que se encontró disminuido en el grupo A, Además se encontró un incremento en frecuencias correspondientes a la banda beta en regiones frontales de ambos hemisferios en el grupo A. Conclusiones. Podría considerarse que el incremento en la banda alfa es característico de la EMTr a 5Hz, mismo que se ve reducido por efecto del escitalopram. Por otro lado, se observo que el grupo A mostro incrementos en fuentes correspondientes a la banda beta como posible efecto relacionado del fármaco antidepresivo.